Entity Detail — Knowledge Graph Node
This page aggregates everything SciDEX knows about MAPK1: its mechanistic relationships (Knowledge Graph edges), hypotheses targeting it, analyses mentioning it, and supporting scientific papers. The interactive graph below shows its immediate neighbors. All content is AI-synthesized from peer-reviewed literature.
MAPK1 is a gene implicated in neurodegeneration research. Key relationships include: therapeutic target, interacts with, associated with. Associated with Aging, Als, Alzheimer. Connected to 273 entities in the SciDEX knowledge graph.
No AI portrait yet
| Gene Symbol | MAPK1 |
| Protein Family | MAP kinase family, CMGC group |
| Protein Type | Kinase |
| Function | is a protein involved in various cellular processes relevant to neurodegeneration. |
| Subcellular Localization | Cytoplasm, nucleus |
| Molecular Weight | 41 kDa |
| Amino Acids | 360 aa |
| Pathways | MAPK, Mapk, MAPK signaling, MAPK pathway |
| UniProt ID | P28482 |
| GeneCards | MAPK1 |
| Human Protein Atlas | MAPK1 |
| Associated Diseases | Aging, Als, Alzheimer, Cancer, Carcinoma |
| Known Drugs/Compounds | Chrysotoxine, DEP, DMP, DOP, Zuojin Pill |
| Interactions | ACTB, ACTG1, Actin, ACVR1, AIFM1, AKT |
| KG Connections | 889 knowledge graph edges |
| Databases | GeneCardsNCBI GeneHPASTRING |
Knowledge base pages for this entity
graph TD
MAPK1["MAPK1"]
MAPK1 -->|"interacts"| APP["APP"]
MAPK1 -->|"inhibits"| Inflammation["Inflammation"]
MAPK1 -->|"inhibits"| Als["Als"]
MAPK1 -->|"inhibits"| Ms["Ms"]
MAPK1 -->|"activates"| Dementia["Dementia"]
MAPK1 -->|"activates"| Alzheimer["Alzheimer"]
MAPK1 -->|"target for"| Cancer["Cancer"]
FOXO3["FOXO3"] -->|"inhibits"| MAPK1
PI3K["PI3K"] -->|"inhibits"| MAPK1
APP -->|"activates"| MAPK1
NFKB1["NFKB1"] -->|"target for"| MAPK1
ERK["ERK"] -->|"target for"| MAPK1
TRIM24["TRIM24"] -->|"target for"| MAPK1
TDP1["TDP1"] -->|"target for"| MAPK1
MAP1LC3B["MAP1LC3B"] -->|"inhibits"| MAPK1| Target | Relation | Type | Str |
|---|---|---|---|
| MAPK1 | encodes | protein | 0.00 |
| Neurodegeneration | involved_in | process | 0.90 |
| Breast Cancer | involved_in | disease | 0.90 |
| Mapk | therapeutic_target | pathway | 0.90 |
| TP53 | interacts_with | protein | 0.89 |
| Breast Cancer Pathogenesis | involved_in | process | 0.85 |
| immunosuppression | upstream_of | process | 0.85 |
| Zuojin Pill | inhibits | drug | 0.80 |
| Wnt signaling | participates_in | pathway | 0.80 |
| Hepatocellular Carcinoma | activates | disease | 0.80 |
| GENES | therapeutic_target | gene | 0.80 |
| Mapk | activates | pathway | 0.80 |
| AKT | therapeutic_target | gene | 0.80 |
| Cancer | therapeutic_target | disease | 0.75 |
| Als | interacts_with | disease | 0.75 |
| APP | interacts_with | protein | 0.71 |
| Apoptosis | therapeutic_target | pathway | 0.70 |
| PIK3CA | associated_with | gene | 0.70 |
| AUTOPHAGY | activates | gene | 0.70 |
| PI3K | treats | gene | 0.70 |
| Mapk | associated_with | pathway | 0.70 |
| PI3K-AKT-mTOR signaling | participates_in | pathway | 0.70 |
| PIK3CA | targets | gene | 0.70 |
| apoptosis pathway | participates_in | pathway | 0.70 |
| Mapk | interacts_with | pathway | 0.70 |
| STAT3 | associated_with | gene | 0.70 |
| NETO2 | activates | gene | 0.70 |
| Nf-Κb | therapeutic_target | pathway | 0.70 |
| Autophagy | activates | pathway | 0.70 |
| Pi3K/Akt | therapeutic_target | pathway | 0.70 |
| ALS | expressed_in | disease | 0.65 |
| Depression | inhibits | disease | 0.65 |
| Alzheimer | inhibits | disease | 0.65 |
| Hepatitis | associated_with | disease | 0.65 |
| ALS | causes | disease | 0.65 |
| Aging | regulates | disease | 0.65 |
| Depression | activates | disease | 0.65 |
| Neuroinflammation | expressed_in | disease | 0.65 |
| Alzheimer | expressed_in | disease | 0.65 |
| Ms | activates | disease | 0.65 |
| Inflammation | causes | disease | 0.65 |
| Diabetes | activates | disease | 0.65 |
| Inflammation | regulates | disease | 0.65 |
| ALS | activates | disease | 0.65 |
| Dementia | activates | disease | 0.65 |
| Cancer | expressed_in | disease | 0.65 |
| Fibrosis | causes | disease | 0.65 |
| Dementia | inhibits | disease | 0.65 |
| Neuroinflammation | inhibits | disease | 0.65 |
| Alzheimer | activates | disease | 0.65 |
| Source | Relation | Type | Str |
|---|---|---|---|
| MAPK1 | encodes | gene | 0.00 |
| Cyclosporine A | upregulates | drug | 0.92 |
| FGF2 | activates | protein | 0.90 |
| DEP | binds | compound | 0.90 |
| KDEL | phosphorylates | receptor | 0.88 |
| DMP | binds | compound | 0.85 |
| DOP | binds | compound | 0.85 |
| FGF2 mutant (K119E/R120E/K125E) | inhibits | protein | 0.85 |
| PRKCD | associated_with | gene | 0.80 |
| Chrysotoxine | targets | compound | 0.80 |
| TERT | activates | gene | 0.80 |
| EGFR | activates | gene | 0.80 |
| PI3K | therapeutic_target | gene | 0.80 |
| MYC | associated_with | gene | 0.78 |
| MTOR | interacts_with | protein | 0.75 |
| MAPK3 | therapeutic_target | gene | 0.70 |
| NFE2L2 | interacts_with | gene | 0.70 |
| MAPK3 | associated_with | gene | 0.70 |
| MAPK3 | activates | gene | 0.70 |
| FN1 | interacts_with | gene | 0.60 |
| MAPK | causes | gene | 0.60 |
| IL-17 | therapeutic_target | gene | 0.60 |
| DEPRESSION | inhibits | gene | 0.60 |
| ROS | inhibits | gene | 0.60 |
| DEMENTIA | inhibits | gene | 0.60 |
| INSULIN RESISTANCE | activates | gene | 0.60 |
| ALZHEIMER'S DISEASE | activates | gene | 0.60 |
| MAPK | treats | gene | 0.60 |
| NFKB1 | therapeutic_target | gene | 0.60 |
| TRIM24 | therapeutic_target | gene | 0.60 |
| TDP1 | therapeutic_target | gene | 0.60 |
| MAPK3 | regulates | gene | 0.60 |
| MMP9 | associated_with | gene | 0.60 |
| MAP2K1 | associated_with | gene | 0.60 |
| IGF1 | associated_with | gene | 0.60 |
| SRC | associated_with | gene | 0.60 |
| IGF1R | associated_with | gene | 0.60 |
| JAK2 | associated_with | gene | 0.60 |
| ERK1 | associated_with | gene | 0.60 |
| MITOCHONDRIA | activates | gene | 0.60 |
| PARKINSON | therapeutic_target | gene | 0.60 |
| HUNTINGTON | therapeutic_target | gene | 0.60 |
| ALZHEIMER | therapeutic_target | gene | 0.60 |
| PSMD14 | interacts_with | gene | 0.60 |
| KRAS | therapeutic_target | gene | 0.60 |
| NF-ΚB | therapeutic_target | gene | 0.60 |
| MITOCHONDRIAL DYSFUNCTION | regulates | gene | 0.60 |
| MAPK | activates | gene | 0.60 |
| RXRA | regulates | gene | 0.60 |
| AKT1 | regulates | gene | 0.60 |
Hypotheses where this entity is a therapeutic target
| Hypothesis | Score | Disease | Analysis |
|---|---|---|---|
| No targeting hypotheses | |||
Scientific analyses that reference this entity
No analyses mention this entity
Experimental studies targeting or related to this entity
| Experiment | Type | Disease | Score | Feasibility | Model | Status | Est. Cost |
|---|---|---|---|---|---|---|---|
| No experiments found | |||||||
Scientific publications cited in analyses involving this entity
| Title & PMID | Authors | Journal | Year | Citations |
|---|---|---|---|---|
| No papers found | ||||
Multi-agent debates referencing this entity
No debates reference this entity
Hypotheses and analyses mentioning MAPK1 in their description or question text
No additional research found